title: Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes.
abstract: Alterations in thyroid hormone levels are found associated with inflammation in patients with non-thyroidal illness (NTIS) and are common in patients with type 2 diabetes mellitus (T2DM). Inflammation has also been linked with development of cardiovascular events (CVE) in T2DM. Our objective was to assess whether thyroid hormone abnormalities typical of NTIS in patients with T2DM are related to inflammation and CVE. This was a cross-sectional study of 140 subjects; 70 with T2DM and 70 as a control group paired by age, sex and body mass index (BMI). We recorded age, sex, BMI, waist/hip ratio, diabetes duration, HbA1c, CVE history, serum amyloid A (SAA), TSH, total (T) and free (F) T4 and T3, reverse T3 (rT3) and TT3/rT3 ratio. Patients with T2DM had lower levels of TT4 (p = 0.012), TT3 (p < 0.001), FT3 (p < 0.001) and TT3/rT3 (p = 0.002). They also showed higher FT4 (p < 0.001) and similar TSH levels (p = 0.627) compared to the control group. SAA levels correlated positively with rT3 (r = 0.45; p < 0.001) and inversely with TT3/rT3 (r = -0.38; p = 0.001). Patients with T2DM and history of CVE had higher rT3 (p = 0.006) and lower TT3/rT3 (p = 0.002), along with higher SAA levels (p = 0.002) than patients without this characteristic. Multiple logistic regression showed that factors independently associated with CVE were older age (OR = 1.159, 95 % CI 1.011-1.329), male sex (OR = 4.391, 95 % CI 1.081-17.829) and higher TT3/rT3 (OR = 0.993, 95 % CI 0.987-0.999). We have confirmed the presence of NTIS in T2DM. We also showed that thyroid hormone abnormalities are associated to inflammatory activity and to CVE in these patients.
authors.affiliation: Division of Endocrinology, Department of Clinical Medicine, School of Medical Sciences, University of Campinas, Campinas, SP, Brazil.
authors.forename: A
authors.initials: A
authors.lastname: Moura Neto
authors.forename: M C R
authors.initials: MC
authors.lastname: Parisi
authors.forename: M A
authors.initials: MA
authors.lastname: Tambascia
authors.forename: E J
authors.initials: EJ
authors.lastname: Pavin
authors.forename: S M
authors.initials: SM
authors.lastname: Alegre
authors.forename: D E
authors.initials: DE
authors.lastname: Zantut-Wittmann
mesh_terms: D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology* / Q000209:etiology; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications* / Q000453:epidemiology*; D003925:Diabetic Angiopathies / Q000097:blood / Q000453:epidemiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013963:Thyroid Hormones / Q000097:blood*
chemical_list: D013963:Thyroid Hormones
references.citation: Circulation. 2004 Jun 1;109(21 Suppl 1):II2-10
references.pmid: 15173056
references.citation: Endocrine. 2012 Jun;41(3):398-409
references.pmid: 22322947
references.citation: Circulation. 2000 Jul 4;102(1):42-7
references.pmid: 10880413
references.citation: Respir Med. 2007 Jul;101(7):1439-46
references.pmid: 17346957
references.citation: Endocr Rev. 2011 Oct;32(5):670-93
references.pmid: 21791567
references.citation: Endocrinology. 2008 May;149(5):2484-93
references.pmid: 18218695
references.citation: Clin Chim Acta. 2006 Apr;366(1-2):74-80
references.pmid: 16343470
references.citation: Circulation. 2003 Feb 11;107(5):708-13
references.pmid: 12578873
references.citation: Diabetes Metab. 2008 Feb;34(1):2-11
references.pmid: 18093861
references.citation: Endocrinol Metab Clin North Am. 2007 Sep;36(3):657-72, vi
references.pmid: 17673123
references.citation: Crit Care Clin. 2006 Jan;22(1):57-86, vi
references.pmid: 16399020
references.citation: J Clin Endocrinol Metab. 2008 Oct;93(10):3671-89
references.pmid: 18664543
references.citation: Curr Opin Endocrinol Diabetes Obes. 2012 Apr;19(2):81-7
references.pmid: 22327367
references.citation: Diabetes Metab. 2012 Jun;38(3):183-91
references.pmid: 22252015
references.citation: Clin Chim Acta. 2007 Feb;376(1-2):72-6
references.pmid: 16916504
references.citation: J Clin Endocrinol Metab. 1984 Sep;59(3):521-5
references.pmid: 6430948
references.citation: J Am Geriatr Soc. 1984 May;32(5):375-9
references.pmid: 6715765
references.citation: PLoS One. 2011;6(6):e20832
references.pmid: 21698184
references.citation: Front Endocrinol (Lausanne). 2012 Jan 26;3:8
references.pmid: 22654851
references.citation: Diabetologia. 1982 Jun;22(6):486-8
references.pmid: 6809514
references.citation: Minerva Med. 1991 Jan-Feb;82(1-2):9-14
references.pmid: 2000180
references.citation: Eur J Endocrinol. 2012 Nov;167(5):719-26
references.pmid: 22956557
references.citation: J Clin Endocrinol Metab. 2007 Aug;92(8):3330-3
references.pmid: 17504898
references.citation: Clin Endocrinol (Oxf). 2013 Mar;78(3):373-8
references.pmid: 22469460
references.citation: Endocrine. 2013 Apr;43(2):351-9
references.pmid: 22810425